InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+62.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Almenoff June Sherie, Director. Insider active across 3 companies, notably Brainstorm Cell Therapeutics INC.. Aggregated, 6 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €7k. Activity tracked since 10 December 2021. The latest transaction was filed on 17 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Almenoff June Sherie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
93 shares@ US$7.1550.0% of flowCommon StockSEC:0001492647-25-000004:0
Canonical exit: 15 Feb 2026 (T+90)
93 shares@ US$7.1550.0% of flowCommon StockSEC:0001492647-25-000003:0
Canonical exit: 15 Feb 2026 (T+90)
3,167 sharesCommon StockSEC:0001578563-25-000199:0
500 shares@ US$12.499100.0% of flowCommon StockSEC:0001578563-24-000441:0
Canonical exit: 10 Feb 2025 (T+90)
2,000 shares0Common StockSEC:0001104659-21-151214:0
2,000 shares0Common StockSEC:0001104659-21-148745:0
6 of 6 declarations
About Almenoff June Sherie
Almenoff June Sherie is an Administrateur at Tenax Therapeutics, INC., Avalo Therapeutics, Inc. and Brainstorm Cell Therapeutics INC. The record shows 6 filings in total, and in the recent filings tracked, acquisitions run from 2021-12-10 to 2025-11-20, with EUR 7005 of buys and EUR 0 of sells.
